Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |